APA (7th ed.) Citation

MD, L., M, H., DS, M., V, N., TE, E., L, F., . . . DN, C. (2004). A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway. The Journal of clinical endocrinology and metabolism, 89(3), 1068. https://doi.org/10.1210/jc.2003-030652

Chicago Style (17th ed.) Citation

MD, Lewis, et al. "A Novel Dysfunctional Growth Hormone Variant (Ile179Met) Exhibits a Decreased Ability to Activate the Extracellular Signal-regulated Kinase Pathway." The Journal of Clinical Endocrinology and Metabolism 89, no. 3 (2004): 1068. https://doi.org/10.1210/jc.2003-030652.

MLA (9th ed.) Citation

MD, Lewis, et al. "A Novel Dysfunctional Growth Hormone Variant (Ile179Met) Exhibits a Decreased Ability to Activate the Extracellular Signal-regulated Kinase Pathway." The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 3, 2004, p. 1068, https://doi.org/10.1210/jc.2003-030652.